In vitro neurotoxic potential of emerging flame retardants on neuroblastoma cells in an acute exposure scenario.

2-ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB) 3-dichloro-2-propyl)phosphate (TDCPP) Bis(2-ethylhexyl)tetrabromophthalate (BEH-TEBP) Flame retardant (FR) In vitro neurotoxicity Triphenyl phosphate (TPhP) Tris(1

Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 17 08 2022
revised: 19 10 2022
accepted: 19 11 2022
pubmed: 26 11 2022
medline: 3 1 2023
entrez: 25 11 2022
Statut: ppublish

Résumé

Since 2004, some legacy flame retardants (FRs) were restricted or removed from the European markets due to their concern on human health. Both organophosphorus FRs (OPFRs) and novel brominated FRs (NBFRs) have replaced them because they are presumably safer and less persistent emerging FRs (EFRs) and their exposure is currently occurring in indoor environments at high levels. Little is known about the neurotoxic potential risk of these EFRs in humans. The present study was aimed at assessing the acute neurotoxicity potential of Tris(1, 3-dichloro-2-propyl)phosphate (TDCPP), triphenyl phosphate (TPhP), Bis(2-ethylhexyl)tetrabromophthalate (BEH-TEBP) and 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB) on human neuroblastoma cells (SH-SY5Y). SH-SY5Y were exposed to these EFRs at low concentrations -ranging 2.5-20 μM. during 2-24 h. We investigated viability, mitochondrial function, oxidative stress, inflammatory response, as well as neural plasticity and development. The results have demonstrated that selected EFRs (TDCPP, TPhP, EH-TBB and BEH-TBP) did not impair neural function on SH-SY5Y as acute response. To the best of our knowledge, this has been the first study focused on evaluating the neural affection of TPhP on SH-SY5Y cells and of EH-TBB and BEH-TBP on neural cells. We also assessed for the first time almost all endpoints after FR exposure on neural cell lines.

Identifiants

pubmed: 36427757
pii: S0887-2333(22)00221-1
doi: 10.1016/j.tiv.2022.105523
pii:
doi:

Substances chimiques

Flame Retardants 0
Dust 0
triphenyl phosphate YZE19Z66EA
Organophosphates 0
Organophosphorus Compounds 0
Halogenated Diphenyl Ethers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105523

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The author declare that they have no known competing financial interest or personal relationship that could have appeared to influence the work reported in this paper.

Auteurs

Roser Esplugas (R)

Environmental Analysis and Management Group, Chemical Engineering Department, Universitat Rovira I Virgili, Tarragona, Spain; Laboratory of Toxicology and Environmental Health, School of Medicine, Universitat Rovira i Virgili, Reus, Spain. Electronic address: roser.esplugas@urv.cat.

Victoria Linares (V)

Laboratory of Toxicology and Environmental Health, School of Medicine, Universitat Rovira i Virgili, Reus, Spain.

Montserrat Bellés (M)

Laboratory of Toxicology and Environmental Health, School of Medicine, Universitat Rovira i Virgili, Reus, Spain.

José L Domingo (JL)

Laboratory of Toxicology and Environmental Health, School of Medicine, Universitat Rovira i Virgili, Reus, Spain.

Marta Schuhmacher (M)

Environmental Analysis and Management Group, Chemical Engineering Department, Universitat Rovira I Virgili, Tarragona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH